Is Oscar Health Stock Still a Buy?
Wall Street thinks health insurance is boring. That's exactly why Oscar Health (NYSE: OSCR) could be your best contrarian play in 2025.This digital-first insurer delivered its first profitable year in 2024 and continued that momentum with exceptional Q1 2025 results: $275 million in net income on $3 billion in revenue, with 42% year-over-year growth. Image source: Getty Images.Continue reading
Wall Street thinks health insurance is boring. That's exactly why Oscar Health (NYSE: OSCR) could be your best contrarian play in 2025.
This digital-first insurer delivered its first profitable year in 2024 and continued that momentum with exceptional Q1 2025 results: $275 million in net income on $3 billion in revenue, with 42% year-over-year growth.
Image source: Getty Images.
